In the rapidly advancing field of biopharmaceuticals, the Combination Antibody Therapy Market has emerged as a revolutionary frontier. By utilizing two or more monoclonal antibodies (mAbs) or next-generation formats like bispecifics, these therapies overcome the limitations of single-agent treatments, offering a multi-pronged attack against complex diseases. As we navigate 2025, this ... https://shashikant873.livejournal.com/3767.html